pharmaphorum

MARCH 4, 2022

With prospects of an early, accelerated approval for Roche’s Alzheimer’s disease candidate gantenerumab looking diminished, the drugmaker has launched a new four-year trial in the hope of building its case for the drug. The new placebo-controlled SKYLINE study will enrol 1,250 people aged 60 to 80 with the earliest biological signs of Alzheimer’s – in other words signs of amyloid accumulation in the central nervous system – but no cognitive impairment.

Hospitals 134

Hospitals 134

Pharmacy Friday Pearls

MARCH 4, 2022

Download PDF. Author: Alyssa Lear, PharmD. Introduction. Recently, oral coronavirus agents showed treatment efficacy in clinical studies for outpatients with COVID-19 Goals of therapy for outpatients with COVID-19: Prevent serious disease, reduce visits to an urgent care/hospital, reduce duration of illness, and reduce death Fluvoxamine is FDA approved for the treatment of obsessive-compulsive disorder, but has recently been studied in COVID-19 infections Paxlovid & molnupiravir are COVID-19

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunization 40

pharmaphorum

MARCH 4, 2022

The pharmaceutical industry is still picking its way through the debris of the pandemic but the gloom can be illuminated by the power of coaching to drive connections and value. It is clear that sales forces and MSL teams need to enhance their skills to make every second of their precious time in front of HCPs count. They are facing unprecedented challenge as traditional routes evaporate which means they need to be pitch perfect when they have a window of attention either in person or across dig

Communication 98

Communication 98

Pharma Times

MARCH 4, 2022

UKHSA reports an increase in norovirus cases throughout educational settings – particularly in nursery and childcare facilities

41

41

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 4, 2022

New survey data from Press Ganey suggests that pharma may be able to get an edge by integrating physician directories into brand websites. When it comes to pharma marketing, historically companies have had to either market direct to consumers — and trust them to find a doctor and bring up the company’s product with them — or to send sales reps to doctors — and hope they had the right mix of potential customers among their patients.

Insurance 97

Insurance Communication Vaccines 97

Pharma Times

MARCH 4, 2022

New detailed datasets will more accurately map out the impact of obesity throughout UK

46

46

pharmaphorum

MARCH 4, 2022

Novo Nordisk’s rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates it will help drive obesity sales to 25 billion kroner ($3.69 billion) in 2025, twice its earlier forecast. Camilla Sylvest, Novo Nordisk’s head of commercial strategy and corporate affairs, said at the company’s Capital Markets Day yesterday that the company expects to meet demand for Wegovy in the US in the second half of

64

64

pharmaphorum

MARCH 4, 2022

Eli Lilly and Incyte’s JAK inhibitor Olumiant reduced the risk of death by 13% in hospitalised COVID-19 patients when added to other drugs, according to new results from the UK RECOVERY trial. The benefit came when Olumiant (baricitinib) added to the steroid dexamethasone and Roche’s IL-6 inhibitor Actemra/RoActemra (tocilizumab), two other anti-inflammatory drugs that have also been shown to improve survival in severe COVID-19 cases, as well as Gilead’s antiviral Veklury (remd

Immunization 52

Immunization Vaccines 52